Medipostco메디포스트
078160 · KOSDAQ · ₩078160 · 메디포스트
₩8,090▼ ₩260 (3.11%)End-of-day · Oct 30, 2026 · End-of-day prices.
Income statement
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₩19B | ₩19B | ₩18B | ₩19B | ₩18B | ₩19B | ₩18B | ₩17B |
| Cost of sales | ₩6.9B | ₩6.2B | ₩6.5B | ₩7.4B | ₩6.8B | ₩7.5B | ₩6.5B | ₩6.6B |
| Gross profit | ₩12B | ₩13B | ₩11B | ₩11B | ₩11B | ₩12B | ₩11B | ₩11B |
| Operating income | −₩24B | −₩17B | −₩21B | −₩14B | −₩19B | −₩14B | −₩19B | −₩15B |
| Net income | ₩43B | −₩11B | −₩69B | ₩7.1B | −₩7.8B | −₩17B | −₩45B | −₩21B |
| Net income to shareholders | ₩32B | −₩11B | −₩28B | −₩17B | −₩24B | −₩16B | −₩40B | −₩18B |
Balance sheet
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Total assets | ₩559B | ₩578B | ₩432B | ₩375B | ₩387B | ₩398B | ₩414B | ₩425B |
| Current assets | ₩248B | ₩270B | ₩128B | ₩89B | ₩103B | ₩117B | ₩135B | ₩148B |
| Cash and equivalents | ₩78B | ₩103B | ₩77B | ₩35B | ₩43B | ₩59B | ₩33B | ₩23B |
| Total liabilities | ₩285B | ₩336B | ₩182B | ₩109B | ₩178B | ₩162B | ₩162B | ₩135B |
| Current liabilities | ₩194B | ₩249B | ₩97B | ₩30B | ₩102B | ₩80B | ₩81B | ₩57B |
| Borrowings | ₩158B | ₩153B | ₩46B | ₩7B | ₩7B | ₩10B | ₩10B | ₩10B |
| Total equity | ₩274B | ₩241B | ₩250B | ₩265B | ₩209B | ₩236B | ₩253B | ₩290B |
| Shareholders' equity | ₩273B | ₩240B | ₩249B | ₩264B | ₩208B | ₩235B | ₩251B | ₩289B |
Cash flow
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | — | — | −₩14B | −₩14B | −₩19B | −₩10B | −₩20B | −₩2.7B |
| Capital spending | ₩678M | ₩2B | ₩101M | ₩1.9B | ₩329M | ₩615M | ₩1.5B | ₩22M |
| Free cash flow | — | — | −₩14B | −₩16B | −₩19B | −₩11B | −₩21B | −₩2.8B |
Consolidated where available. Amounts in won.
Also known as: Medipostco / 메디포스트 / 078160 / KRX:078160
Source: KRX statistical information